Drug information provided by: Merative, Micromedex®
Infigratinib is used to treat cholangiocarcinoma (bile duct cancer) that has spread or cannot be removed by surgery. It is used in patients who have already tried cancer treatment before and have a certain type of abnormal FGFR2 gene in their cancer. Your doctor will test for the presence of this gene.
Infigratinib is an antineoplastic (cancer) agent. It interferes with the growth of cancer cells, which are eventually destroyed by the body.
This medicine is available only with your doctor's prescription.
Portions of this document last updated: Feb. 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift can go twice as far to advance cancer research and care!